期刊名称：IRANIAN JOURNAL OF IMMUNOLOGY
|
ISSN： | 1735-1383
|
|
出版频率： | Quarterly
|
|
出版社： | SHIRAZ INST CANCER RES, SHIRAZ UNIV MED SCI, IRANIAN SOC IMMUNOL & ALLERGY, PO BOX 71345-3119, SHIRAZ, IRAN, 00000
|
|
出版社网址： | http://iji.sums.ac.ir/
|
|
期刊网址： | http://iji.sums.ac.ir/
|
|
影响因子： | 1.603 |
| 主题范畴： | IMMUNOLOGY |
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Iranian Journal of Immunology (I.J.I) is an internationally disseminated peer-reviewed publication and
publishes a broad range of experimental and theoretical studies concerned with all aspects of immunology.
Types of papers accepted:
The Journal will welcome original and review articles on basic and clinical Immunology, Immunogenetics,
Transplantation Immunology, Immunohematology, Cancer Immunology, and Allergy. The Journal will also
welcome short papers and letters to the Editor.
Iranian Journal of Immunology is indexed in the following indexing systems:
MEDLINE,
PUBMED,
EMBASE,
EMNursing,
GEOBASE,
Cambridge Scientific Abstracts,
Chemical Abstracts,
Global Health,
Index Medicus for Eastern Mediterranean Region (IMEMR),
and SCOPUS.
And is approved by Medical Journals Commission of the Ministry of Health and Medical Education.
Instructions to Authors
Aims and Scopes:
The Iranian Journal of Immunology (IJI) is an internationally-disseminated peer-reviewed quaternary publication that publishes a broad range of experimental and theoretical studies concerned with all aspects of immunology.
Types of Papers Accepted:
The main part of each issue will be devoted to original research papers which should present new results of interest to a broad spectrum of immunologists. Such papers must describe significant and original observations to be critically evaluated and, if necessary, repeated. The journal will include review articles dealing with particular subject areas in a thoughtful and personal manner. Subjects that are undergoing rapid change or that merit a new conceptual approach will have priority. The Journal will welcome review articles on basic and clinical immunology, immunogenetics, transplantation immunology, immunohematology, cancer immunology and allergy. The Journal will also consider short communications, case reports and letters to the Editor.
Submission:
Submit a copy of your manuscript typed in Microsoft Word for PC (PDF is not an acceptable format). Graphs should be submitted as separate files prepared by Microsoft Excel program. Figures should also be submitted as separate files in TIFF or PCX format and should have a resolution of at least 300 dpi. Manuscripts that do not conform to these specifications may not be accepted. All the aforementioned files should be submitted as attachments to iji@sums.ac.ir, accompanied by a covering letter to the Editor-in-Chief, containing the title and the authors' names and indicating that the manuscript has not been published or submitted for publication elsewhere. The files could also be electronically sent to the Editor-in-Chief:
Dr. Abbas Ghaderi, PhD
Professor of Immunology,
Shiraz Institute for Cancer Research,
Medical School,
Shiraz University of Medical Sciences,
Shiraz, Iran.
P.O. Box: 71345-3119,
Phone: (+98711) 2303687,
Fax: (+98711) 2304952,
E-mail: ghaderia@sums.ac.ir Submitted materials will be considered for publication with the understanding that they are solely submitted to the IJI, are not currently submitted to other journals, and have not been published elsewhere either in paper form or electronically. Abstracts presented in a congress, oral presentations and theses are excluded from this rule.
Preparation of Manuscripts:
All manuscripts should be typewritten in English with double spacing throughout (including figure legends and references) and with 2.5 cm (1 in.) margins. All pages should be numbered sequentially in the upper right hand corner, including Title page, Tables and References.
Title Page:
- Title of the article (should be as short as possible, containing adequate information
regarding the contents, without any abbreviation).
- Running title (not in excess of 50 characters).
- The authors' full first names and surnames.
- Affiliation(s)/Address(es) should be followed by the name, the full postal address,
the e-mail address and the fax/telephone numbers of the corresponding author.
- Keywords: Three to six words in alphabetic order selected according to the terms recommended in the last version of the Medical Subject Headings (MeSH).
Abstract:
A Research article should have a structured abstract with the following organization: Background, describing the motivations of the study; Objective(s), explaining the aim of the current work; Method(s), clarifying how the work was carried out; Results, revealing the main findings and their significance; and Conclusion(s), disclosing the main message of the article. The abstract should not exceed 250 words in length. Do not use reference citations in the Abstract). Short papers and Short communications should have the same structure of the abstract as a research article but with no more than 150 words. Case reports and Letters to the editor do not require abstracts. A review article may have an unstructured abstract (one paragraph not more than 300 words). It is preferable not to use any abbreviations in the abstract section.
Structure of articles:
IJI requires that depending on the type of articles, the submitted manuscripts should be divided into the following sections:
- Review Articles: Title page, Abstract, Introduction, Methods, Primary and secondary topic headings (as many as required), Discussion, Conclusion, Acknowledgements, References, Tables, Legends.
- Research Articles: Title page, Abstract, Introduction, Materials and Methods, Results, Discussion, Acknowledgements, References, Tables, Legends.
- Short Papers and Short Communications: Title page, Abstract, Introduction, Materials and Methods, Results and Discussion (combined), Acknowledgements, References, Tables, Legends. The length of these articles should not exceed 2500 words.
- Case Reports: Title page, Introduction, The case, Discussion, Acknowledgements, References, Tables, Legends. The length of such articles should not exceed 2000 words.
- Letters to the eEditor: Title page, Letter, Acknowledgements, References. The length of such letters should not exceed 1500 words. Acknowledgements:
All contributors who do not meet the criteria for authorship should be covered in the acknowledgement section. It should include persons who provided technical help, writing assistance and the departmental head when providing only general support. Financial and material support should also be acknowledged by citing the grant number.
Tables:
Should be numbered with Arabic numerals and appear after References. They should be self-explanatory, clearly designed, and not duplicating the text.
Figures:
Graphs should be submitted as separate files prepared by Microsoft Excel program. Figures should be submitted as separate files in TIFF or PCX format and should have a resolution of at least 300 dpi. Manuscripts that do not conform to these specifications may not be accepted at the editor's discretion.
References:
Should be numbered consecutively with Arabic numerals in parentheses as they appear in the text. A number must be used if the authors are named in the sentence/text. Bibliographies cited in tables and figures should be numbered according to the site where the corresponding table or figure is first referenced. When multiple references are cited at a given place in the text, use a hyphen to join the first and last numbers that are inclusive. Use commas (without spaces) to separate non-inclusive numbers in a multiple citation eg. 2,3,4,5,7,10 is abbreviated to (2-5,7,10). Do not use a hyphen if there are no numbers cited between the numbers used (eg. 1-2). Periodicals should be abbreviated according to the Index Medicus (Vancouver Style). Include the name of all authors, if there are six or less authors. Print names of the first six authors followed by "et al." when there are more than six authors. References to books should include Author(s), Title, Edition, Place of publication, Publisher and Year of publication. Chapters in a book should appear as Author(s), Title of chapter, Editor(s), Name of the book, Place of publication, Publisher, Year of publication and Pages. References to electronic journals should include Author(s), Title of article, Abbreviated title of electronic journal, [serial online], Publication year, month(s), [cited year month (abbreviated) day], Volume number, Issue number, Page numbers or number of screens, available from, URL address underlined:
- Doroudchi M, Dehaghani AS, Ghaderi A. Preferential placental transfer of Helicobacter pylori specific IgG. J Matern Fetal Neonatal Med. 2004;16:297-301.
- Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell J. Molecular cell biology. 3rd ed. New York: Scientific American; 1995.
- Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG, (Editor). Basic and clinical pharmacology. 6th ed. Norwalk (CN): Appleton and Lange; 1995. p. 361-80.
- Morse SS. Factors in the emergence of infectious disease. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1999 Dec 25]; 1(1):[24 screens]. Available from:URL: http://www/cdc/gov/ncidoc/EID/eid.htm
Inclusive page numbers should be given for all references. Articles in press might appear in the reference list, however unpublished material and personal communications should not be cited in the reference list, though they could be mentioned in parenthesis in the text.
Ethics:
Ethical considerations must be addressed in the Materials and Methods section.
1) Please state that informed consent was obtained from all human adult participants and from the parents or legal guardians of minors. Include the name of the appropriate institutional review board that approved the project.
2) Indicate in the text that the maintenance and care of experimental animals complies with National Institute of Health guidelines for the humane use of laboratory animals, or with those of your Institute or agency.
Conflicts of Interest:
Authors must acknowledge and declare all sources of funding and potential conflicting interest, such as receiving funds or fees by, or holding stocks and shares in an organization that may profit or lose through publication of the paper. Declaring a competing interest will not lead to automatic rejection of the paper, but we would like to be made aware of it.
Page charges:
There are no page charges for the publication of papers in Iranian Journal of Immunology.
Copyright:
At the time of sending the manuscript, the authors are requested to download the Copyright Agreement Form available at www.iji.ir (IJI website) and send its signed proof by ALL authors, along with a covering letter from the corresponding author indicating their agreements upon submission to and the right to reproduce and distribute the article for IJI.
Upon receiving the signed proof of the copyright agreement, the editorial board of IJI, reserves the right to accept or reject the article in any stage and any time or delete a part of the text, tables or figures, if necessary.
Reviewing Process:
The submitted manuscripts will firstly be assessed from the editorial points of view. Should the manuscript meet the basic editorial requirements, it will enter the peer-review process. The manuscript will then be sent to one in-office and two out of office referees for review. The corresponding author will then be informed of the referees�remarks. It is highly recommended that the authors provide the names and the complete addresses (Postal address, Fax number and E-mail) of at least three qualified reviewers capable of reviewing their manuscripts.
Disposal of Material:
Once published, all copies of the manuscript, the correspondence and the art work will be held for 6 months before disposal.
Editorial Board
|
Editor-in-Chief:
Abbas Ghaderi, Ph.D.
Professor of Immunology,
Shiraz Institute for Cancer Research
Medical School,
Shiraz University of Medical Sciences,
Shiraz-Iran
P.O. Box: 71345-1798
Email: ghaderia@sums.ac.ir
Tel: +98 711 230 3687
Fax:+98 711 230 4952
Publisher:
Shiraz Institute for Cancer Research,
Shiraz, Iran
Website: http://www.icr.ir
Mirror: http://icr.sums.ac.ir
Production Manager:
Saeed Nemati, D.D.S
Email: nematis@sums.ac.ir
|
Associate Editor:
Mehrnoosh Doroudchi, Ph.D.
Assistant Professor of Immunology,
Shiraz University of Medical Sciences,
Shiraz-Iran
Email:mdoroud@sums.ac.ir
Editorial Assistants:
Mahmoud Vessal, Ph.D. (Copy Editor)
Safoura Sameni, BSc
Somayeh Hooshmand, MSc
Web Designer & Editor:
Seyyed Hedayat Allah Faghih, MD.
Information & Communication Technology(ICT) Management,
Shiraz University of Medical Sciences,
Shiraz-Iran
Email: faghihha@sums.ac.ir
Tel: +98 711 233 9652
Fax:+98 711 233 1631 |
Chairman Editorial Board:
Mohammad Vodjgani, Ph.D (Tehran-Iran)
Tehran University of Medical Sciences,
E-mail: vojganim@sina.tums.ac.ir
Editorial Board:
Aghamohammadi A. (Tehran-Iran)
Alimohammadian M.H. (Tehran-Iran)
Amirghofran Z. (Shiraz-Iran)
Bahram S. (Strasburg-France)
Delves P (London-UK)
Eslami M.B. (Tehran-Iran)
Farid Hosseini R. (Mashhad-Iran)
Hassan Z.M. (Tehran-Iran)
Inoko H. (Tokyo-Japan)
Jeddi-Tehrani M. (Tehran-Iran)
Kashef S (Shiraz Iran)
Khazaie K. (Harvard-USA)
Kumar P.V. (Shiraz-Iran)
| Mageed R.A. (London-UK)
Mahmoudi M. (Mashhad-Iran)
Masoud A. (Tehran-Iran)
Moazzeni S.M. (Tehran-Iran)
Modjtahedi H. (Surrey-UK)
Moin M. (Tehran-Iran)
Mytilineos J. (Ulm-Germany)
Nikbin B. (Tehran-Iran)
Nicknam M.H. (Tehran-Iran)
Osterborg A. (Stockholm-Sweden)
Pakzad P. (Tehran-Iran)
Pourpak Z. (Tehran-Iran)
Rabbani H (Stockholm- Sweden)
Rajalingam R (UCLA-USA)
Rezaei A. (Isfahan-Iran)
Salekmoghadam A. (Tehran-Iran)
Shokri F. (Tehran-Iran) |
|
